Adma Biologics (ADMA) Amortizatization of Intangibles (2011 - 2025)
Adma Biologics (ADMA) reported Amortizatization of Intangibles of $197000.0 for Q4 2025, down 10.05% on a YoY basis from $219000.0 in Q4 2024, and up 15.88% quarter-over-quarter from $170000.0 in Q3 2025.
Adma Biologics (ADMA) Amortizatization of Intangibles (2011 - 2025) Analysis & Trends
Adma Biologics has reported Amortizatization of Intangibles for 13 years, with the latest figure at $197000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles fell 10.05% year-over-year to $197000.0; the trailing twelve-month figure through Dec 2025 stood at $717000.0 (down 24.61% YoY), and the FY2025 full-year result was $717000.0, down 24.61% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $197000.0, up from $170000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $981066.0 in Q3 2022, with the low at $160000.0 in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $428050.0 across 5 years, with a median of $454075.5 in 2021.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles soared 101.87% — and 2024, when it sank 68.62%.
- Adma Biologics' Amortizatization of Intangibles stood at $502858.0 in 2021, then retreated by 1.79% to $493873.0 in 2022, then soared by 41.33% to $698000.0 in 2023, then slumped by 68.62% to $219000.0 in 2024, then dropped by 10.05% to $197000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $197000.0 (Q4 2025), $170000.0 (Q3 2025), and $160000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 197,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 197,000.00 |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 252,000.00 |
| Sep 30, 2024 | 252,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Mar 31, 2024 | 253,000.00 |
| Mar 31, 2024 | 253,000.00 |
| Dec 31, 2023 | 698,000.00 |
| Dec 31, 2023 | 698,000.00 |
| Sep 30, 2023 | 721,000.00 |
| Sep 30, 2023 | 721,000.00 |